[{"indications": "Indications\u00a0pruritus in eczema; depressive illness\r\n(section 4.3.1)", "name": "DOXEPIN HYDROCHLORIDE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "13 Skin", "13.3 Topical local anaesthetics and antipruritics"], "cautions": "Cautions\u00a0susceptibility to angle-closure glaucoma; urinary retention; mania; cardiac arrhythmias; severe\r\nheart disease; avoid application to large\r\nareas; interactions: Appendix 1 (antidepressants,\r\ntricyclic) Driving\u00a0Drowsiness may affect performance\r\nof skilled tasks (e.g. driving); effects\r\nof alcohol enhanced", "side-effects": "Side-effects\u00a0drowsiness; local burning, stinging, irritation,\r\ntingling and rash; systemic side-effects such as antimuscarinic effects,\r\nheadache, fever, dizziness, gastro-intestinal disturbances also reported", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/74563.htm", "doses": ["adult and child over 12 years, apply thinly 3\u20134 times daily;\r\nusual max. 3\u00a0g per application; usual total max. 12\u00a0g daily; coverage\r\nshould be less than 10% of body surface area"], "pregnancy": "Pregnancy\u00a0manufacturer advises use only if potential benefit\r\noutweighs risk"}]